We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
-13.17%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$4.31B
AUM Growth
-$768M
Cap. Flow
-$24.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
22.74%
Holding
1,425
New
109
Increased
486
Reduced
323
Closed
110

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$38.9M
2
COP icon
ConocoPhillips
COP
+$22.8M
3
LIN icon
Linde
LIN
+$21.7M
4
XOM icon
ExxonMobil
XOM
+$19.2M
5
MRK icon
Merck
MRK
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 18.23%
2 Healthcare 15.18%
3 Financials 14.65%
4 Consumer Discretionary 13.31%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAP icon
1276
SAP
SAP
$236B
$17K ﹤0.01%
168
-12,908
-99% -$1.37M
SSTI icon
1277
SoundThinking
SSTI
$106M
$17K ﹤0.01%
+544
New +$20.3K
TRQ
1278
DELISTED
Turquoise Hill Resources Ltd
TRQ
$17K ﹤0.01%
1,016
-59
-5% -$1.06K
SNNA
1279
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$17K ﹤0.01%
7,344
-21,454
-74% -$189K
ASMB icon
1280
Assembly Biosciences
ASMB
$536M
$16K ﹤0.01%
+61
New +$17.6K
KGC icon
1281
Kinross Gold
KGC
$32.6B
$16K ﹤0.01%
4,818
TWI icon
1282
Titan International
TWI
$450M
$16K ﹤0.01%
3,536
+1,696
+92% +$11K
RP
1283
DELISTED
RealPage, Inc.
RP
$16K ﹤0.01%
+336
New +$17.6K
BB icon
1284
BlackBerry
BB
$5.14B
$15K ﹤0.01%
2,024
INXN
1285
DELISTED
Interxion Holding N.V.
INXN
$15K ﹤0.01%
+286
New +$17.2K
FIVN icon
1286
FIVE9
FIVN
$2.33B
$14K ﹤0.01%
+320
New +$12.9K
PAYC icon
1287
Paycom
PAYC
$9.52B
$14K ﹤0.01%
+112
New +$14.3K
RETA
1288
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14K ﹤0.01%
+252
New +$15.4K
ZEN
1289
DELISTED
ZENDESK INC
ZEN
$14K ﹤0.01%
+240
New +$13.8K
CHRS icon
1290
Coherus Oncology
CHRS
$181M
$13K ﹤0.01%
+1,408
New +$16.3K
GDDY icon
1291
GoDaddy
GDDY
$11.6B
$13K ﹤0.01%
+192
New +$13.1K
QTWO icon
1292
Q2 Holdings
QTWO
$3.9B
$13K ﹤0.01%
+264
New +$13.5K
DNLI icon
1293
Denali Therapeutics
DNLI
$4.04B
$12K ﹤0.01%
+594
New +$10.8K
DNTH icon
1294
Dianthus Therapeutics
DNTH
$6.29B
$12K ﹤0.01%
133
-109
-45% -$14.9K
KALV
1295
DELISTED
KalVista Pharmaceuticals
KALV
$12K ﹤0.01%
+608
New +$12.2K
NEWR
1296
DELISTED
New Relic, Inc.
NEWR
$12K ﹤0.01%
+154
New +$13K
PRTK
1297
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$12K ﹤0.01%
+2,288
New +$17.4K
VCIT icon
1298
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
$11K ﹤0.01%
136
APPF icon
1299
AppFolio
APPF
$6.97B
$10K ﹤0.01%
+176
New +$10.7K
CBAY
1300
DELISTED
Cymabay Therapeutics
CBAY
$10K ﹤0.01%
+1,264
New +$12K

Similar funds

Meadow Creek Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Meadow Creek Investment Management held 1,425 positions worth $4.31B, down 15% from $5.08B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q4 2018 filing shows 109 new, 486 increased, 323 reduced and 110 closed positions. Its largest new stake was Linde: 137,592 shares worth $21.5M. The largest sale was Express Scripts Holding Company, an estimated $65.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Meadow Creek Investment Management's largest Q4 2018 buy was Linde: 137,592 shares worth $21.5M.
  • Meadow Creek Investment Management added most to Cigna in Q4 2018, an estimated $38.9M increase.
  • Meadow Creek Investment Management's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $20.9M.
  • Meadow Creek Investment Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $65.1M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $4.31B portfolio in Q4 2018.
  • Meadow Creek Investment Management opened 109 new positions and closed 110 in Q4 2018.
  • Meadow Creek Investment Management's portfolio value fell 15% quarter-over-quarter to $4.31B.

Based on Meadow Creek Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.